Trazabilidad en APAC

La industria farmacéutica de la India se rige por varios organismos reguladores, y el cumplimiento de las normas de trazabilidad es crucial para garantizar la seguridad e integridad de los medicamentos.

Pakistan has established a robust regulatory framework for track and trace systems, spearheaded by the Drug Regulatory Authority of Pakistan (DRAP) and the Federal Board of Revenue (FBR). These comprehensive regulations, particularly SRO 470(I)/2017 for pharmaceuticals and the broader FBR Track and Trace System, represent Pakistan's commitment to combating counterfeit products, enhancing tax compliance, and ensuring supply chain transparency across critical sectors including pharmaceuticals, tobacco, cement, sugar, and fertilizers.

In the Philippines, the Food and Drug Administration (FDA) has established a comprehensive track and trace system designed to enhance pharmaceutical security and combat counterfeit products. Through FDA Circular No. 2014-011 and subsequent regulations, the Philippines demonstrates its commitment to protecting public health by implementing robust traceability measures that ensure product authenticity and safety throughout the pharmaceutical supply chain.

The National Medicines Regulatory Authority (NMRA) of Sri Lanka stands as the cornerstone of pharmaceutical safety and quality assurance in the island nation. Established in 2015 through an Act of Parliament, NMRA serves as an independent authority under the Ministry of Health, dedicated to protecting public health by ensuring that all medicinal products, medical devices, and borderline products meet stringent standards of safety, efficacy, and quality throughout the pharmaceutical supply chain.

In Uzbekistan, the government has established one of Central Asia's most comprehensive pharmaceutical traceability frameworks through the ASL BELGISI digital system. Managed by the national operator CRPT Turon and modeled after Russia's proven Chestny ZNAK platform, this robust regulatory structure demonstrates Uzbekistan's commitment to safeguarding public health and ensuring the authenticity of pharmaceutical products throughout the entire supply chain.